SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 246 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $321,000 | +9.6% | 11,000 | 0.0% | 0.05% | +9.5% |
| Q3 2021 | $293,000 | -13.6% | 11,000 | 0.0% | 0.04% | -6.7% |
| Q2 2021 | $339,000 | +17.7% | 11,000 | 0.0% | 0.04% | +9.8% |
| Q1 2021 | $288,000 | -37.4% | 11,000 | -39.9% | 0.04% | -36.9% |
| Q4 2020 | $460,000 | +20.7% | 18,300 | 0.0% | 0.06% | 0.0% |
| Q3 2020 | $381,000 | -12.4% | 18,300 | 0.0% | 0.06% | -7.1% |
| Q2 2020 | $435,000 | +15.1% | 18,300 | -12.9% | 0.07% | +14.8% |
| Q1 2020 | $378,000 | -24.1% | 21,000 | 0.0% | 0.06% | +22.0% |
| Q4 2019 | $498,000 | +105.8% | 21,000 | +138.6% | 0.05% | +100.0% |
| Q3 2019 | $242,000 | – | 8,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |